Biomerica, Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Hp Detect? Stool Antigen ELISA test (K232892), a new product that is designed to detect the presence of the H. pylori bacteria. The Biomerica Hp Detect?

test detects the presence of the H. pylori bacteria which infects approximately 35% of the U.S. population. Over 80% of gastric cancers are attributed to H. pylori infection, and gastric cancer is the third most common cause of cancer-related death worldwide. Physicians and medical centers will be able use the results from the Hp Detect?

Stool Antigen test to diagnose the presence of H. pylori and assess H. pylori infection status after treatment.